Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine
New England Journal of Medicine · 20.11.2025 · 393 (20) · 2001-2011
DOI: 10.1056/nejmoa2416779 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift New England Journal of Medicine, erschienen am 20.11.2025. Verfasst von David Fitz-Patrick und 19 weiteren Autor:innen. Beteiligte Einrichtung: East-West Medical Research Institute, Honolulu. Hauptthemen laut MEDLINE: Immunogenicity, Vaccine, Influenza Vaccines, Influenza, Human, mRNA Vaccines. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: CSRD VA, Pfizer, Pfizer Inc.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- East-West Medical Research Institute, Honolulu.
- Vaccine Research and Development, Pfizer, Marlow, United Kingdom.
- Kaiser Permanente Washington Health Research Institute, Seattle.
- Vaccine Research and Development, Pfizer, Pearl River, NY.
- PMG Research of Wilmington, Wilmington, NC.
- Entrust Clinical Research, Miami.
ORCID-Profile: Lisa A Jackson
Förderung
- CSRD VA
- Pfizer
- Pfizer Inc
Zitieren
APA
Fitz-Patrick, D., McVinnie, D. S., Jackson, L. A., Crowther, G., Geevarughese, A., Cannon, K. D., Garcia, L. M., Pineiro Puebla, Y., Yi, Z., Cunliffe, L., Maniar, A., Zareba, A. M., Ianos, C. A., Gomme, E., Koury, K., Suphaphiphat Allen, P., Anderson, A. S., Gurtman, A., Lindert, K., & Pfizer C4781004 Trial Investigators (2025). Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine. New England Journal of Medicine, 393(20), 2001-2011. https://doi.org/10.1056/nejmoa2416779
Vancouver
Fitz-Patrick D, McVinnie DS, Jackson LA, Crowther G, Geevarughese A, Cannon KD, et al. Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine. New England Journal of Medicine. 2025;393(20):2001-2011. doi:10.1056/nejmoa2416779
BibTeX
@article{FitzPatrick2025,
author = {Fitz-Patrick, David and McVinnie, Donald S and Jackson, Lisa A and Crowther, Graham and Geevarughese, Anita and Cannon, Kevin D and Garcia, Lazaro M and Pineiro Puebla, Yanely and Yi, Zhuobiao and Cunliffe, Luke and Maniar, Alok and Zareba, Agnieszka M and Ianos, Claudia Ana and Gomme, Emily and Koury, Kenneth and Suphaphiphat Allen, Pirada and Anderson, Annaliesa S and Gurtman, Alejandra and Lindert, Kelly and Pfizer C4781004 Trial Investigators, Pfizer C4781004 Trial Investigators},
title = {Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine},
journal = {New England Journal of Medicine},
year = {2025},
volume = {393},
number = {20},
pages = {2001--2011},
doi = {10.1056/nejmoa2416779}
}
EUVIMED